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The major capsid protein, Vp54, of chlorella virus PBCV-1 is a glycoprotein that contains either one glycan of ;30 sugar
residues or two similar glycans of ;15 residues. Previous analysis of PBCV-1 antigenic mutants that contained altered Vp54
glycans led to the conclusion that unlike other glycoprotein-containing viruses, most, if not all, of the enzymes involved in the
synthesis of the Vp54 glycan are probably encoded by PBCV-1 (I.-N. Wang et al., 1993, Proc. Natl. Acad. Sci. USA 90,
3840–3844). In this report we used molecular and genetic approaches to begin to identify these virus genes. Comparing the
deduced amino acid sequences of the putative 375 PBCV-1 protein-encoding genes to databases identified seven potential
glycosyltransferases. One gene, designated a64r, encodes a 638-amino-acid protein that has four motifs conserved in “Fringe
type” glycosyltransferases. Analysis of 13 PBCV-1 antigenic mutants revealed mutations in a64r that correlated with a
specific antigenic variation. Dual-infection experiments with different antigenic mutants indicated that viruses that contained
wild-type a64r could complement and recombine with viruses that contained mutant a64r to form wild-type virus. Therefore,
we conclude that a64r encodes a glycosyltransferase involved in synthesizing the Vp54 glycan. This is the first report of a
virus-encoded glycosyltransferase involved in protein glycosylation. © 2001 Academic Press
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Paramecium bursaria chlorella virus-1 (PBCV-1) is the
prototype of a family (Phycodnaviridae, genus chlorovi-
rus; Van Etten, 2000) of large, genetically complex,
dsDNA viruses that infect certain unicellular, endosym-
biotic, chlorella-like green algae (Van Etten and Meints,
1999). The PBCV-1 genome contains 330,744 bp that
encode 700 open reading frames (ORFs) ($65 codons),
of which 375 are probably protein-encoding genes; the
virus also contains 10 tRNA genes (Li et al., 1995, 1997;
Lu et al., 1995, 1996; Kutish et al., 1996; Nishida et al.,
1999). The following properties make chlorella viruses
amenable to study: (i) The host alga can be grown in
culture in liquid and on solid media. (ii) Virus infection
can be synchronized. (iii) Milligram quantities of virus
can be purified from a few liters of culture. (iv) Chlorella
viruses are the only viruses infecting a unicellular eu-
karyote for which a plaque assay has been developed
(Van Etten et al., 1983b; Van Etten and Meints, 1999).
However, one shortcoming of the chlorella virus system
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332is our inability to specifically manipulate the virus ge-
nome with molecular techniques.
The PBCV-1 virion is a large icosahedron, 190 nm in
diameter, that contains ;50 virion-associated proteins
and a membrane internal to the outer capsid shell. The
major virion protein Vp54 [M r 54 kDa as determined by
sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS–PAGE)] forms the outer capsid and ac-
counts for ;40% of the total virion protein (5040 mole-
cules/particle) (Skrdla et al., 1984; Yan et al., 2000). The
gene, a430l, for Vp54 encodes a peptide with a predicted
MW of 48,165 (Graves and Meints, 1992). Native Vp54
contains at least one myristate residue, is a glycoprotein,
and lacks the N-terminal initiating Met residue (Skrdla et
al., 1984; Graves and Meints, 1992; Wang et al., 1993; Que
et al., 1994). Sugar analyses indicate that the Vp54 glycan
contains seven neutral sugars: glucose, fucose, galac-
tose, mannose, xylose, rhamnose, and arabinose (Wang
et al., 1993; M. V. Graves and J. L. Van Etten, unpublished
results). Taking into account the posttranslational modi-
fications and the ratios of the sugars, we predict that the
Vp54 glycan consists of either a single oligosaccharide
of ;30 sugar residues or two similar oligosaccharides of
;15 residues. The oligosaccharide lacks N-acetylglu-
cosamine, a sugar commonly found in Asn-linked (N-
linked) and many O-linked glycoproteins produced via
the cellular endoplasmic reticulum (ER)–Golgi pathway
(Reuter and Gabius, 1999). The glycan portion of Vp54 is
believed to be located on the external surface of PBCV-1.
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333PBCV-1-ENCODED GLYCOSYLTRANSFERASETypically, virus proteins are glycosylated by host-
encoded glycosyltransferases located in the ER and
Golgi. Nascent glycoproteins are then targeted to a
host membrane where the virus particle acquires them
by budding through the membrane, often as they are
released from the cell (Stephens and Compans, 1988;
Doms et al., 1993; Knipe, 1996; Olofsson and Hansen,
998). Consequently, the glycan portion of virus glyco-
roteins is specific to the host, and changes in the
ligosaccharide structure require either growing the
irus in a different host or altering the glycosylation
ite in the peptide portion of the glycoprotein. How-
ver, glycosylation of PBCV-1 Vp54 does not follow this
aradigm. The initial observations that led to this con-
lusion arose from antibody studies. Polyclonal anti-
erum prepared against intact PBCV-1 virions inhibits
irus plaque formation by agglutinating particles. How-
ver, spontaneously derived, antiserum-resistant mu-
ants of PBCV-1 occur at a frequency of ;1026. These
antiserum-resistant mutants fall into four serologically
distinct classes (Table 1 and Fig. 1) (Wang et al., 1993).
olyclonal antisera prepared against members of each
f these four antigenic classes react exclusively with
he Vp54 equivalent from the viruses in the class used
n the immunization. The Vp54 equivalents from the
utants migrate in a distinctive fashion on SDS–PAGE;
he size of Vp54 in each mutant is smaller than that of
ild-type Vp54. Western blot analyses of the Vp54
roteins, before and after removing the glycan, estab-
T
Properties of Antigenic
Antigenic classes
Class
Proposed
genotype
Mr Vp54:
SDS–PAGE Virus
Wild type wt 54 kDa PBCV-1
91 mp91 53 kDa P91
EPA-1 mepa1 52 kDa EPA-1
EPA-2
EPA-3
P31
P1050
P1056
E11 me11 51 kDa E11
P41
P1210
P1219
P100 mp100 50.5 kDa P100
a Calculated by subtracting the deduced peptide mass minus the N-
rom the MW determined by mass spectrometry.
b nd, not determined.ished that the antigenic classes reflect differences in
he Vp54 glycan. In addition, the ratio of the sevenugars associated with Vp54 from PBCV-1 and the
utants varies in a sequential manner (Fig. 1) that
orrelates with antigenicity and Vp54 migration on
DS–PAGE.
Additional observations that indicate Vp54 glycosyla-
ion is atypical include: (i) Unlike viruses that acquire
heir glycoprotein(s) by budding through a membrane,
ntact infectious PBCV-1 particles accumulate inside the
ell 30–40 min before virus release (Van Etten et al.,
983b). (ii) The nucleotide sequences of the Vp54 a430l
ene in each of the mutants are identical to that of
BCV-1 (Wang et al., 1993). (iii) Each of the mutants is
grown in the same host. (iv) The antibodies to the virus
do not react with host oligosaccharides. (v) Drugs, such
as tunicamycin and brefeldin A, that inhibit ER–Golgi-
localized N-linked glycosylation of proteins and ER to
Golgi protein transport, respectively (Doms et al., 1989;
Lippincott-Schwartz et al., 1989), do not affect PBCV-1
replication nor the M r of Vp54 at concentrations lethal to
the host alga (Que et al., 1994). Taken together, these
results imply that PBCV-1 encodes most, if not all, the
enzymes involved in constructing the complex oligosac-
charide attached to Vp54.
This report describes the identification of a PBCV-1
gene that encodes one of the putative glycosyltrans-
ferases involved in glycosylation of Vp54. In addition,
we determined the masses of Vp54 from PBCV-1 and
four antigenic mutants using mass spectrometry and
s Derived from PBCV-1
Properties of members of each antigenic class
ctual genotype
MW Vp54: mass
spectrometry
Total glycan
massa
wt 53,790 5545
ndb 52,780 4535
-epa1, ma122r-epa1 51,560 3315
-epa2 nd nd
-epa3 nd nd
-p31 51,593 3348
nd nd
nd nd
-epa1, ma122r-epa1 nd nd
nd nd nd
, De11 nd nd
, De11 nd nd
-p31 51,038 2793
l initiating Met residue (48,017) and the mass of one myristate (228.4)ABLE 1
Classe
A
ma64r
ma64r
ma64r
ma64r
Da64r
Da64r
ma64r
Da64r
Da64r
ma64r
terminaused these values to calculate the sizes of the gly-
cans.
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334 GRAVES ET AL.RESULTS
dentification of a PBCV-1-encoded
lycosyltransferase, A64R
To identify candidate PBCV-1-encoded proteins that
ould be involved in glycosylation of Vp54, we compared
he deduced amino acid sequences of the 375 putative
BCV-1 protein-encoding genes to databases with
ASTA, BLAST, and PSI-BLAST programs. These analy-
es identified seven possible glycosyltransferase encod-
ng genes, a64r, a111r, a114r, a222r, a328l, a473l, and
546l (Table 2). Interestingly, none of these putative
BCV-1-encoded glycosyltransferase proteins has an
dentifiable signal peptide that would target it to the ER.
SORT, a University of Osaka-based cellular protein lo-
FIG. 1. Proposed model for the structure of the Vp54 glycan based on
Three identical branches are shown extending from a “core glycan” tha
The nature of the sugar linkages is unknown. PBCV-1-encoded glyco
substrates. Presumably the sugars can be added only in the order p
remaining distal sugars. This model is based on the predicted number
provides a simple explanation for single gene mutations affecting the
reduced in mannose and lacks arabinose, whereas mutant EPA-1
corresponds to a mutation in the gene for glycosyltransferase IX. Addi
for glycosyltransferases I–IV) have been identified although the P10
glycosyltransferase VII as the product of PBCV-1 gene a64r.alization prediction program, indicates that all of these
roteins, with the exception of A473L, are probably lo-
e
Aated in the cytoplasm. A473L is predicted to be located
n the plasma membrane.
Several factors focused our initial efforts on the a64r
ene. (i) Six PBCV-1 mutants have been identified that
elong in the EPA-1 antigenic group (proposed genotype
epa1) (Table 1). (ii) Sugar analysis of the glycan(s) from
wo of these antigenic mutants, EPA-1 and P31, indicated
hat members of this class lack two sugars, mannose
nd arabinose, that account for 9 to 12 sugar residues in
he wild-type glycan (Wang et al., 1993; M. V. Graves and
. L. Van Etten, unpublished results). (iii) Two of the
utants, P1050 and P1056, are missing about 37 kb of
he left end of their respective viral genomes (Fig. 2A;
andstein et al., 1995). This region includes 66 ORFs
A1R to A66L) of which 29 are predicted to be protein-
scribed antigenic mutants of PBCV-1, modified from Wang et al. (1993).
ts of approximately 12 residues of three of the seven different sugars.
ferases are responsible for the transfer of the sugars to preexisting
d, i.e., a defect in glycosyltransferase V prevents the addition of the
ecules of each sugar residue missing from the antigenic mutants and
n of more than one molecule of each sugar. Note that mutant P91 is
annose and arabinose. No antigenic mutant has been found that
, no antigenic mutants smaller than P100 (i.e., mutations in the genes
n still contains 12–15 sugar residues. The current report identifiesthe de
t consis
syltrans
resente
of mol
additio
lacks m
tionallyncoding genes including a64r. (iv) The 638-amino-acid
64R protein (MW 74,912) (Fig. 3A) contains motifs com-
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335PBCV-1-ENCODED GLYCOSYLTRANSFERASEmon to galactosyltransferases from Schizosaccharomy-
ces pombe (GMA12) and Saccharomyces cerevisiae
MNN10) (Table 2) as well as the “Fringe class” of glyco-
yltransferases (Fig. 3B) (Bru¨ckner et al., 2000; Yan et al.,
997). Five conserved domains, designated 1–5, have
een identified in this class of enzymes (Yan et al., 1997).
omains 3 and 5 contain the proposed catalytic amino
cids, the “DXD” sequence in domain 3 and the first “D”
esidue in domain 5. The A64R protein appears to con-
ain domains 2–5 although the spacing between some of
he domains differs from that of Fringe (Fig. 3B). This is
specially true between domains 4 and 5, which are
eparated by 11 amino acids in Fringe but 482 amino
cids in A64R. As mentioned above, the A64R protein
ontains no identifiable signal peptide that would target
he protein to the ER nor does it contain a membrane-
panning domain as do the GMA12, MNN10, and Fringe
roteins.
These features prompted us to sequence a64r from
embers of the antigenic classes to determine if muta-
ions in a64r correlated with the EPA-1 antigenic variation
i.e., does a64r 5 epa1). The a64r gene was PCR ampli-
ied, cloned, and sequenced from PBCV-1 and the anti-
enic mutants listed in Table 1. The sequences of the
ragments amplified from PBCV-1 and mutant P41 were
dentical to the original PBCV-1 a64r sequence (Lu et al.,
995). The a64r sequences from mutants EPA-1 (ma64r-
pa1), EPA-3 (ma64r-epa3), P31 (ma64r-p31), E11 (ma64r-
pa1), and P100 (ma64r-p31) each contained single nu-
T
PBCV-1-Encoded Proteins wit
Protein Amino acids FASTA Amino acid
A64R 638 129 30%a/
123 32%/6
A111R 389 26%/1
23%/1
A114R 485 150 27%/1
143 25%/1
A222Rc 432 173 22%/3
171 20%/3
143 22%/3
130 22%/3
A328L 355 93 24%/1
A473L 517 535 33%/3
416 32%/2
26%/2
A546Lc 321 154 30%/1
128 25%/2
81 41%/4
a Percentage amino acid identity.
b Amino acid overlap.
c ORFs corrected for sequencing errors in original published sequeleotide substitutions compared to PBCV-1: ma64r-epa1
as a C to T substitution at position 35,194; ma64r-p31
c
ias a G to A substitution at position 35,320; ma64r-epa3
as a G to A substitution at position 35,196. Each of these
hanges produces a single amino acid substitution in the
64R protein: S to L at amino acid 79 in mA64R-EPA1, D
o N at amino acid 80 in mA64R-EPA3, G to E at amino
cid 121 in mA64R-P31 (Fig. 3B). The changes in mA64R-
PA1 and mA64R-EPA3 are in the proposed active site
XD motif in domain 3 while the change in mA64R-P31 is
n domain 4. E11, which was originally derived from
PA-1, had the same mutation in a64r as EPA-1, as ex-
ected. Similarly, P100, which was derived from mutant
31, had the same mutation in a64r as P31. However,
ince E11 and P100 are in different antigenic classes
ompared to the viruses from which they were derived,
hey presumably have second mutations in another gene
i.e., me11 and mp100, respectively) involved in glycosyl-
tion. EPA-2 a64r (ma64r-epa2) contains an additional A
n a stretch of five A residues from position 35,220 to
5,224. This additional base creates a frame shift that
runcates the A64R protein (Fig. 3B).
The base substitution in ma64r-epa1 changes the se-
uence GATTC, which is recognized by the restriction
ndonuclease HinfI (GANTC), to GATTT (Fig. 2B). To
onfirm that this mutation was not a PCR cloning artifact,
64r was amplified, using the same PCR procedure, from
iral DNAs isolated from purified plaques of PBCV-1 and
he antigenic mutants. HinfI digestion products were
nalyzed. As seen in Fig. 2C (lane EPA), the restriction
attern of the product produced from the EPA-1 plaque
arity to Glycosyltransferases
ty Organism/enzyme [accession number]
S. pombe/a-1,2-galactosyltransferase GMA12 [Q09174]
Yeast/galactosyltransferase MNN10 [P50108]
Enterococcus/putative glycosyltransferase [AF071085]
Enterococcus/putative glycosyltransferase [AF071085]
Vibrio/fucosyltransferase [AB012956]
Dictyostelium/fucosyltransferase [AF076599]
Aquifex/cellulose synthase [AE000738]
Agrobacterium/cellulose synthase [L38609]
Acetobacter/cellulose synthase [P19449]
Acetobacter/cellulose synthase [P21877]
Haemophilus/hypothetical glycosyltransferase [Q57125]
Acetobacter/cellulose synthase [P21877]
Agrobacterium/cellulose synthase [L38609]
Rhizobium/N-acetylglucosaminyltransferase [P50357]
Streptomyces/glucosyltransferase [AB005901]
E. coli/ORF704 putative mannosyltransferase [AB010150]
E. coli/ORF469 putative mannosyltransferase [AB010150]ABLE 2
h Simil
identi
63b
5
32
41
50
92
68
56
13
21
66
03
45
37
38
20
2ontained an additional 618-bp fragment and was miss-
ng the 253- and 365-bp fragments of PBCV-1 (lane wt)
s
p
o
d
l
a
B
p
w
E CV-1 (la
t B8a-EP
336 GRAVES ET AL.and the other antigenic mutants (not shown). This indi-
cates that the HinfI site at position 35,194 is indeed
missing in ma64r-epa1 and confirms that the C to T
ubstitution is a true mutation. Additionally, this mutation
rovides a RFLP marker that can be used to identify the
FIG. 2. (A) Physical map of the left end of the PBCV-1 genome (1–9
ocation of e11 are shown. Viruses P1050 and P1056 are missing the le
re missing five additional genes relative to P1050 and P1056 (DP121
amHI fragment B8a. (B) Schematic of the a64r PCR product amplified fr
roducts are shown. The HinfI site missing in ma64r-epa1 is marked w
t) and EPA-1 (lane EPA) digested with HinfI. The sizes (in bp) of the fr
PA-1 DNA is indicated to the right (*). (D) Genomic DNAs of viruses PB
he locations of restriction fragment B8a containing wta122r (left) andrigin of the a64r gene in the recombination experiments
escribed below.Restoration of wild-type glycosylation via virus
complementation and recombination
To verify that a64r is equivalent to epa-1, we took a
genetic approach. PBCV-1 temperature-sensitive mu-
ucleotides). The positions of a64r and a122r as well as the predicted
kb of the genome (DP1050/P1056). Deletion mutants P1210 and P1219
). The a122r gene from EPA-1 (ma122r-epa1) is missing 561 bp from
PBCV-1 genome. The locations of the HinfI sites and sizes of digestion
sterisk (*). (C) a64r PCR products obtained from viruses PBCV-1 (lane
ts are indicated to the left. The extra 618-bp band produced from virus
ne wt) and EPA-1 (lane EPA) digested with BamHI. The arrows indicate
A-1 containing ma122r-epa1 (right).0,000 n
ft ;37
0/P1219
om the
ith an a
agmentants recombine at a frequency of ;1% (Tessman, 1985).
We examined the ability of antigenic mutant viruses
pa
1
p
(
c
n n, in t
a nd L357
337PBCV-1-ENCODED GLYCOSYLTRANSFERASEEPA-1 (mepa1), P31 (mepa1), E11 (mepa1, me11), and P41
(me11) to recombine to wild type (Fig. 4A). These four
viruses were selected for the following reasons: (i) Vi-
ruses EPA-1, P31, and E11 should not complement each
other to form a wild-type glycan because they each
contain single missense mutations in a64r (Fig. 4B).
Recombination between these viruses would be rare or
would not occur. (ii) Virus P41 (me11) contains wild-type
a64r and therefore should be able to complement and
recombine with both EPA-1 and P31 to form a wild-type
glycan (Fig. 4C). (iii) Recombination between viruses E11
and P41 to wild type should be extremely rare and
complementation should not occur because they pre-
sumably have mutations in the same gene, i.e., e11.
Algal cultures (2 3 107 cells) were co-inoculated with
these viruses each at a multiplicity of infection (m.o.i.) of
5. After the cells lysed, the progeny viruses were as-
sayed for antigenic class using the appropriate antisera
in a plaque inhibition assay (Table 3). All of the R1
progeny from the EPA-1 3 E11, EPA-1 3 P31, and P31 3
E11 or the single-virus (not shown) infections were sen-
FIG. 3. Deduced amino acid sequence of PBCV-1 A64R (A) and alig
rotein (B). Conserved domains are denoted by angled arrows and num
z ). Numbers in brackets (, .) indicate the numbers of amino acids b
onserved substitutions by (:). The amino acid substitutions in EPA-1,
umbers to the right of each row in the alignment refer to the positio
ccession numbers of PBCV-1 A64R and Fringe protein are U42580 asitive to either aEPA-1 or aE11 antisera (i.e., all the R1
rogeny were one of the parental types). However, 0.5
mnd 1.4%, respectively, of the R1 progeny from the EPA-
3 P41 and P31 3 P41 infections were resistant to both
parental antisera. Combining aEPA-1, aE11, and aPBCV-1
antisera completely inhibited plaque formation by these
progeny viruses. Therefore, virus P41 complemented vi-
ruses EPA-1 and P31, producing viruses with wild-type
(PBCV-1) glycans. This result establishes that viruses in
the EPA-1 and E11 antigenic classes are in independent
complementation groups and therefore have mutations
in different genes.
Nine R1 progeny from the EPA-1 3 P41 cross that were
resistant to the parental antiserum were purified from
plaques, passed through the chlorella host one time, and
then analyzed. To determine the origin of a64r in each of
the viruses, HinfI fragments of PCR products were ana-
lyzed as described for Fig. 2C. Four of the progeny
viruses (R1-1, -4, -6, and -7) contained ma64r-epa1. The
remaining five progeny viruses contained wta64r. Each of
the progeny viruses was tested by the antiserum plaque
inhibition assay. The four viruses that contained ma64r-
epa1 were sensitive to aEPA-1 antiserum while the re-
of PBCV-1 A64R to the conserved domains of the Drosophila Fringe
2–5. The proposed active site “D” residues of Fringe are indicated by
the conserved domains. Identical amino acids are indicated by (_) and
EPA-3, and P31 are indicated below the PBCV-1 A64R sequence. The
he respective protein, of the last amino acid shown in that row. The
70, respectively.nment
bered
etween
EPA-2,aining viruses (wta64r) were sensitive to aE11 anti-
serum. The fact that all nine of these progeny were
338 GRAVES ET AL.initially resistant to the parental antisera indicates that
they arose from complementation between wta64r of P41
and wte11 of EPA-1, but none resulted from recombina-
tion between these two genes.
To determine if any of these progeny viruses were
EPA-1/P41 recombinants, we took advantage of the fact
that the EPA-1 virus carries an additional RFLP marker in
another gene, a122r, which is ;28 kb from a64r (Fig. 2A).
This gene encodes a 260-kDa virus structural protein
(Vp260). EPA-1 ma122r-epa1 lacks 561 bp, resulting in a
truncated Vp260 protein (Wang et al., 1993; Que et al.,
1994). This deletion produces a shift in the migration of a
BamHI restriction fragment, B8a, in the genomic DNA
(Fig. 2D, compare lanes wt and EPA). Virus P41 carries
wta122r. Genomic DNAs from the same nine R1 progeny
were digested with BamHI and the patterns were com-
pared to those of PBCV-1 and EPA-1 (Table 4). Four of the
FIG. 4. Complementation/recombination strategy. (A) List of virus p
predicted outcome of each cross. (B) Crossing virus EPA-1 with E11 pr
ma64r-epa1. Crossing virus P31 with E11 produces similar results. (C)
crossing EPA-1 with P41. The wild-type progeny can be selected for by
P31 with P41 produces similar results.progeny viruses (R1-1, -3, -4, and -6) definitely were the
result of recombination events that had occurred some-where between a64r and a122r. Since none of these
recombinants were phenotypically wild type, e11 must
be located between a64r and a122r and probably near
a64r.
Although the same RFLP analysis could not be con-
ducted with the progeny from the P31 3 P41 cross, R1
progeny resistant to the parental antisera were purified
from 10 plaques, passed through the chlorella host, and
tested by the antiserum plaque inhibition assay. As with
the R1 progeny of the EPA-1 3 P41 cross, all of these
viruses were resistant to aPBCV-1 antiserum and all
were sensitive to either aEPA-1 or aE11 antisera (not
shown). Again these results indicate complementation,
but no recombination, between a64r and e11 from the
two parental viruses.
To select for true recombinants, bulk R1 progeny from
the EPA-1 3 P41 and P31 3 P41 crosses were treated
ed in the complementation and recombination experiments and the
only antigenic mutant recombinant progeny since both viruses carry
tigenic mutant and wild-type recombinant progeny are produced from
the total progeny with antisera to the parental viruses. Crossing virusairs us
oduces
Both an
treatingwith aEPA-1 and aE11 antisera to enrich for viruses with
the wild-type Vp54 glycan. As indicated above, most of
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339PBCV-1-ENCODED GLYCOSYLTRANSFERASEthese progeny arose by complementation, but not re-
combination, between P41 wta64r and EPA-1 or P31
wte11 and therefore will revert to one of the parental
antigenic types after subsequent passage. Only viruses
that are true a64r 3 e11 recombinants will remain wild
ype. Therefore, algal cultures were inoculated with
hese wild-type coat protein-enriched viruses at a low
.o.i. (0.1) and the progeny analyzed by the antiserum
laque inhibition assay (Table 3). Again, the majority of
he R2 progeny were of either parental antigenic type.
owever, 1.3% of the EPA-1 3 P41 and 1.0% of the P31 3
41 R2 progeny were resistant to both aEPA-1 and aE11
ntisera.
Ten R2 progeny from the EPA-1 3 P41 cross that were
esistant to both parental antisera were purified from
laques, passed through the chlorella host one time, and
urther analyzed (Table 4). Nine of the viruses (R2-1, -2, -3,
4, -5, -7, -8, -9, and -10) contained wta64r. Seven of these
viruses (R2-1, -2, -3, -4, -5, -7, and -8) contained ma122r-
pa1 while the remaining 2 (R2-9 and -10) contained
ta122r. Each of these 9 viruses was sensitive to PBCV-1
ntiserum and resistant to both parental antisera.
learly, 7 of the viruses (R2-1, -2, -3, -4, -5, -7, and -8) were
41/EPA-1 recombinants while the remaining 2 (R2-9 and
0) were either recombinants that arose via double-
rossover events [i.e., wta64r (P41)/wte11 (EPA-1)/
wta122r (P41)] or me11 to wte11 revertants. The 10th
virus (R2-6) contained ma64r-epa1 and ma122r-epa1, but
was sensitive to aPBCV-1 antiserum and resistant to the
parental antisera. This virus may be a ma64r-epa1 to
wta64r second-site revertant, i.e., have a compensatory
mutation in a64r.
Ten R2 progeny plaques from the P31 3 P41 infections
that were resistant to the parental antisera also were
analyzed by the antiserum plaque inhibition assay. Eight
T
Titer of R1 and R2 Progeny b
Lysate
None aEPA-
pfu/ml pfu/ml
1 progeny
EPA-1 3 P31 2.0 3 109 0
EPA-1 3 E11 3.2 3 109 0
EPA-1 3 P41 3.2 3 109 1.6 3 107
P31 3 E11 4.3 3 109 0
P31 3 P41 2.0 3 109 2.7 3 107
E11 3 P41 3.7 3 109 600
R2 progeny
EPA-1 3 P31 1.6 3 1010 2.1 3 108
P31 3 P41 1.4 3 1010 1.4 3 108of the 10 remained sensitive to PBCV-1 antiserum and
resistant to the parental antisera. These results suggestrecombination between P41 wta64r and P31 wte11. The
remaining 2 viruses were resistant to all three antisera.
Expression of a64r
A Northern blot of total RNAs isolated from uninfected
and PBCV-1-infected chlorella was probed with a 32P-
abeled ssDNA “antisense” probe specific for a64r (Fig.
A). This probe hybridizes to a single 2.2-kb RNA that first
ppears between 30 and 45 min postinfection (p.i.),
eaches its highest level at 60 min p.i., and then de-
reases gradually through the remainder of the infection
ycle. This RNA is sufficient to encode a protein of 638
mino acid residues and since it appears prior to initia-
ion of viral DNA replication, which begins at 60–90 min
.i., a64r is an early gene. Previously it was shown that
ranscription of the coat protein gene (a430l) and produc-
ion of mature Vp54 begins 60–90 min p.i. and continues
or the remainder of the viral life cycle (Graves and
eints, 1992). We would expect genes that modify (i.e.,
lycosylate) Vp54 to be expressed at the same time or
arlier than a430l and to continue for the remainder of
he virus life cycle. The expression of a64r fits this ex-
ectation.
resence of a64r in other chlorella viruses
Including PBCV-1, we have partially characterized a
total of 37 viruses that infect Chlorella strain NC64A
(NC64A viruses) and 5 viruses that infect Chlorella strain
Pbi (Pbi viruses). NC64A viruses do not infect Chlorella
Pbi and vice versa. The NC64A viruses have been di-
vided into 16 subclasses based upon plaque size, levels
of DNA methylation, and their reactivity with aPBCV-1
ntiserum (Van Etten et al., 1991). Since aPBCV-1 anti-
serum reacts predominantly with the Vp54 glycan, the
nd after Antisera Treatment
Antisera treatment
11 aEPA-1 1 aE11 1 aPBCV-1
% total pfu/ml % total
0 0 0
0 0 0
0.5 0 0
0 0 0
1.4 0 0
1.6 3 1025 0 0
1.3 660 4 3 1026
1.0 100 7 3 1027ABLE 3
efore a
1 1 aEfact that some NC64A viruses do not react with this
antiserum indicates that not all viruses contain the same
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340 GRAVES ET AL.glycan. Therefore, we probed a dot blot (Fig. 5B) contain-
ing the genomic DNAs of all 37 NC64A viruses, all 5 of
the Pbi viruses, and the Chlorella NC64A host with the
same a64r probe used in the Northern analysis de-
scribed above. Results were as follows: (i) The probe did
not hybridize to the host Chlorella NC64A genome. (ii)
The probe hybridized to 26 of the 37 NC64A virus ge-
nomes. Twenty-four of these 26 viruses reacted with the
aPBCV-1 antiserum; the 2 viruses (XZ-4A and XZ-5A) that
did not are members of the same subclass. (iii) The
probe hybridized weakly or not at all to the remaining 11
NC64A viruses. None of these 11 NC64A viruses reacted
with the aPBCV-1 antiserum. (iv) The probe did not hy-
ridize to any Pbi viruses. It is interesting that there is an
lmost exact correlation between hybridization of the
64r probe to a NC64A virus genome and reaction of that
irus with aPBCV-1 antiserum. This finding provides ad-
ditional support for the notion that a64r encodes a pro-
tein involved in the production of the PBCV-1 Vp54 gly-
can. The 11 NC64A viruses that neither hybridized to the
a64r probe nor reacted with the aPBCV-1 antiserum, as
T
Analysis of EPA
Virus
Genotype
a64rb e11c a122rd
EPA-1 parent mepa1 wt mepa1
P41 parent wt me11 wt
R1 progeny
R1-1e mepa1 wt wt
R1-2 wt me11 wt
R1-3e wt me11 mepa1
R1-4e mepa1 wt wt
R1-5 wt me11 wt
R1-6e mepa1 wt wt
R1-7 mepa1 wt mepa1
R1-8 wt me11 wt
R1-9 wt me11 wt
R2 progeny
R2-1e wt wt mepa1
R2-2e wt wt mepa1
R2-3e wt wt mepa1
R2-4e wt wt mepa1
R2-5e wt wt mepa1
R2-6 mepa1 wt mepa1
R2-7e wt wt mepa1
R2-8e wt wt mepa1
R2-9 wt wt wt
R2-10 wt wt wt
a (1) inhibits plaque formation, (2) no effect on plaque formation.
b Determined by HinfI digestion of a64r PCR product.
c Inferred by antigenic phenotype.
d Determined by BamHI digestion of genomic DNA.
e EPA-1/P41 recombinant viruses.ell as viruses XZ-4A and XZ-5A, did not react with
ntisera to the PBCV-1 antigenic mutants.
m
bstimation of the size of the Vp54 glycan
The masses of the purified Vp54 proteins from PBCV-1
nd four antigenic mutants, P91, EPA-1, P31, and P100,
ere determined using mass spectrometry and were
sed to calculate the sizes of the corresponding Vp54
lycans (Table 1) by assuming that mature Vp54 protein
ontains one myristic acid group (MW 228) and using the
eptide MW (minus the N-terminal Met) of 48,017. Of note
s the fact that the MWs of the Vp54 glycans from viruses
PA-1 and P31 differ by 33 Da. These two viruses are in
he same antigenic class and were predicted to have the
ame mass. This small mass difference suggests that at
east one other modification to the protein and/or glycan
ay occur (e.g., methylation), but this modification ap-
arently has no effect on antigenicity. In addition, the
asses of the glycans determined by mass spectrome-
ry, while close (i.e., within ;30 Da), do not match exactly
he masses of the glycans predicted from the sugar
ompositions previously reported by Wang et al. (1993).
his also suggests that there may be some additional
41 R1 and R2
Reaction with antiseraa
Antigenic classEPA-1 aE11 aPBCV-1
1 2 2 EPA-1
2 1 2 E11
1 2 2 EPA-1
2 1 2 E11
2 1 2 E11
1 2 2 EPA-1
2 1 2 E11
1 2 2 EPA-1
1 2 2 EPA-1
2 1 2 E11
2 1 2 E11
2 2 1 PBCV-1
2 2 1 PBCV-1
2 2 1 PBCV-1
2 2 1 PBCV-1
2 2 1 PBCV-1
2 2 1 PBCV-1
2 2 1 PBCV-1
2 2 1 PBCV-1
2 2 1 PBCV-1
2 2 1 PBCV-1ABLE 4
-1 3 P
aodifications to the protein and/or the glycan. It should
e noted though that these slight mass differences are
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341PBCV-1-ENCODED GLYCOSYLTRANSFERASEwithin the mass accuracy of the instrumentation used
(60.05%).
DISCUSSION
PBCV-1 gene a64r encodes a glycosyltransferase
Analysis of the PBCV-1 genomic sequence revealed
seven potential glycosyltransferases. None of these
seven proteins are predicted to be located in the ER or
Golgi by the PSORT algorithm. In this report, we establish
that mutations in one of these putative glycosyltrans-
FIG. 5. Expression of a64r during PBCV-1 infection and presence of
a64r in other chlorella viruses. (A) Northern blot of total RNAs isolated
from uninfected (lane 0) and infected algae at the indicated times (min)
p.i. hybridized to a ssDNA probe corresponding to a64r. (B) Dot blot of
genomic DNAs from host Chlorella NC64A, PBCV-1, and 41 additional
chlorella virus isolates hybridized to the same probe as in (A). The
spots contain 1.0, 0.5, 0.25, and 0.125 mg DNA (left to right). The NC64A
iruses have been divided into 16 subclasses and are grouped accord-
ngly. Viruses that do not react with antiserum to PBCV-1 nor any of the
ntigenic mutants are indicated by an asterisk (*). Viruses CVA-1,
VB-1, CVG-1, CVM-1, and CVR-1 infect Chlorella Pbi (Pbi viruses).ferase genes, a64r, correlate perfectly with one class
(EPA-1) of PBCV-1 antigenic mutants (Wang et al., 1993).
g
wThree of the mutants in this class, EPA-1, EPA-3, and P31,
each have single, unique nucleotide substitutions in a64r
that result in distinct amino acid substitutions. Further-
more, these amino acid substitutions are in two of the
conserved glycosyltransferase domains; substitutions in
mA64R-EPA1 and mA64R-EPA3 are in the DXD catalytic
motif and mA64R-P31 is in conserved domain 4. Another
antigenic mutant, EPA-2, contained an additional nucle-
otide in a64r that shifts the frame to truncate the A64R
protein. The remaining two viruses in the EPA-1 class,
P1050 and P1056, are deletion mutants that lack a64r
(Landstein et al., 1995).
Antigenic mutants complement and recombine to
form wild-type Vp54 glycans
Virus recombination experiments establish that a64r
encodes a protein (glycosyltransferase) involved in Vp54
glycosylation. Both antigenic mutants EPA-1 (ma64r-
epa1, wte11) and P31 (ma64r-p31, wte11) were able to
complement and recombine with antigenic mutant P41
(wta64r, me11) to produce progeny viruses with a wild-
type glycan. Viruses with mutations in a64r (i.e., EPA-1 3
P31, EPA-1 3 E11, and P31 3 E11) neither complemented
nor recombined to produce a wild-type glycan. This was
true even for viruses EPA-1 and P31 that have separate
distinct mutations in a64r. These two viruses can poten-
tially recombine to wild type, but since the two mutations
are only 126 bp apart the frequency would be low. Finally,
there was a 100% correlation between the presence of
ma64r-epa1 in a recombinant EPA-1 3 P41 R1 genome
and expression of the EPA-1 antigenic phenotype by that
virus. These results establish that two distinct comple-
mentation groups corresponding to the EPA-1 and E11
antigenic classes exist, one of the genes being a64r. Of
interest is the fact that viruses E11 and P41, which are in
the same antigenic class, formed a small number (1.6 3
1025%, Table 3) of R1 progeny viruses with wild-type
lycan. This result also supports the notion of the E11-
lass viruses belonging to a single complementation
roup. If E11 and P41 had mutations in separate genes,
hen one would expect roughly 1% of the R1 progeny to
ave a wild-type coat protein glycan due to complemen-
ation between the two viruses, similar to the results from
he EPA-1 3 P41 and P31 3 P41 crosses (Table 3, see
iscussion below). However, the extremely low number
f wild-type R1 progeny suggests that the E11 and P41
iruses probably have separate mutations in the same
ene (i.e., e11) that are sufficiently far apart to allow
etectable recombination.
lycosylation gene e11 is linked to a64r
Approximately 1% of the R1 progeny from the EPA-1 3
41 and P31 3 P41 crosses had a wild-type coat protein
lycan, indicating, at the very least, that 1% of the cells
ere doubly infected and complementation between the
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342 GRAVES ET AL.two viruses had occurred. RFLP analysis of 9 EPA-1 3
P41 wild-type R1 progeny using a64r and another gene,
122r, indicated that the recombination frequency be-
ween these two genes, separated by ;28 kb, was at
east 45%. Since none of these viruses produced a wild-
ype Vp54 glycan after subsequent passage, comple-
entation, but no recombination, between a64r and e11
ad occurred. After subsequent passage of the total
ild-type R1 progeny from the EPA-1 3 P41 and P31 3
41 crosses, ;99% of the R2 progeny had reverted to
ne of the parental antigenic types. These results con-
irm that the vast majority of the wild-type R1 progeny
rose via complementation. However, ;1% of the R2
rogeny did remain wild type, suggesting that recombi-
ation between a64r and e11 had occurred at a fre-
quency of ;2% [i.e., an additional 1% of the progeny
would be the reciprocal recombinants that retained the
mutant antigenic phenotype (see Fig. 4C) for a total of 2%
recombinants]. RFLP analysis of 10 EPA-1 3 P41 wild-
type R2 progeny demonstrated that 7 of the viruses did
contain P41/EPA-1 recombinant genomes [i.e., wta64r
(P41)/wte11, ma122r-epa1 (EPA-1)]. Therefore, we con-
clude that e11 is located between a64r and a122r and
that a64r and e11 are closely linked. To this end, 2 other
members of the E11 antigenic class, viruses P1210 and
P1219, are, like viruses P1050 and P1056, deletion mu-
tants of PBCV-1 missing part of the left end of the ge-
nome (Fig. 2A; Landstein et al., 1995). These 2 viruses
are missing five additional genes, relative to P1050 and
P1056, all of which are within 5 kb to the right of a64r (i.e.,
between a64r and a122r). Therefore, one of these five
genes probably corresponds to e11. None of the putative
proteins encoded by these genes resembles known gly-
cosyltransferases although one, A71R, slightly resem-
bles an Escherichia coli glucokinase.
Expression of a64r and its distribution among other
chlorella viruses
The timing of a64r expression, just prior to and during
synthesis of the Vp54 protein, and its distribution among
other chlorella viruses also are consistent with the con-
clusion that it encodes a glycosyltransferase involved in
Vp54 glycosylation. Southern hybridization analysis of 37
other NC64A viruses indicated that all 24 viruses that
react with aPBCV-1 antiserum contain a64r, whereas 11
ther viruses that do not react with this antiserum lack
he gene. These other 11 viruses also do not react with
ntiserum to any of the four PBCV-1 antigenic mutants,
ndicating that they are not simply variants of the PBCV-1
lycan, but probably encode separate sets of glycosyla-
ion enzymes.
Although the enzyme reaction catalyzed by A64R isnknown, we hypothesize it might be a mannosyltrans-
erase for the following reason. The EPA-1 glycan lacks
u
coth mannose and arabinose compared to wild-type
lycan, whereas virus P91, a member of the antigenic
lass with the largest Vp54 mutant glycan, lacks arabi-
ose (Fig. 1) (Wang et al., 1993; M. V. Graves and J. L. Van
tten, unpublished results). The fact that wild-type A64R
ncoded by one virus can complement a mutant A64R
ncoded by another virus in a dual infection of the same
ell suggests that A64R, or its product, is “freely diffus-
ble” throughout the infected cell. Chlorella viruses as-
emble in viral assembly centers (VACs) located in the
ytoplasm (Meints et al., 1986). Therefore, it would ap-
ear that separate viruses infecting the same cell do not
ecessarily form distinct VACs. Also, since viral genomes
an recombine, they must occasionally be in close prox-
mity with one another.
BCV-1-encoded protein glycosylation may resemble
n ancestral pathway
Research on PBCV-1 protein glycosylation is signifi-
ant for at least five reasons: (i) PBCV-1 is the only virus
nown to encode enzymes involved in polysaccharide
ynthesis. For example, PBCV-1 encodes the glycosyl-
ransferase, hyaluronan synthase (HAS) (DeAngelis et
l., 1997). Hyaluronan (HA) is a linear polysaccharide
onsisting of alternating glucuronic acid and N-acetyl-
lucosamine residues. The PBCV-1 HAS enzyme pro-
uces authentic HA that accumulates on the surface of
he infected host alga (Graves et al., 1999). In addition,
PBCV-1 encodes two enzymes that produce sugar pre-
cursors of HA: glutamine:fructose-6-phosphate amido-
transferase (GFAT) and UDP-glucose dehydrogenase
(UDP-GlcDH) (Landstein et al., 1998). GFAT produces
glucosamine 6-phosphate, a precursor for UDP–N-
acetylglucosamine synthesis, and UDP-GlcDH produces
UDP–glucuronic acid. (ii) This paper is the first report of
a virus encoding enzymes involved in protein glycosyla-
tion. However, a recent report indicates that herpesvirus
type 4 encodes a functional b-1,6-N-acetylglucosaminyl-
ransferase of unknown function (Vanderplasschen et al.,
000). (iii) The predicted cytoplasmic location of A64R
nd the other PBCV-1-encoded putative glycosyltrans-
erases suggests that Vp54 glycosylation occurs in the
ytoplasm, thus indicating that the process differs from
R–Golgi protein glycosylation. Host-encoded cytoplas-
ic O-linked glycosylation of virus-encoded proteins oc-
urs, but typically only one sugar residue, N-acetylglu-
osamine, is added to the protein (Hart, 1997). For ex-
mple, the fiber protein of adenovirus serotype-2 is
odified with a single N-acetylglucosamine residue in
he amino-terminal portion of the protein (Caillet-Boudin
t al., 1989; Mullis et al., 1990). (iv) The size and com-
lexity of the Vp54 glycan(s) (i.e., ;30 residues of seven
ifferent sugars) suggest that the virus is a source of
nique and probably soluble glycosyltransferases that
ould prove useful for glycobiology studies. (v) A recent
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343PBCV-1-ENCODED GLYCOSYLTRANSFERASEphylogenetic analysis of eukaryotic DNA polymerases
identified the phycodnavirus DNA polymerases as near
the root of all eukaryotic d DNA polymerases (Villarreal,
999; Villarreal and DeFilippis, 2000). This analysis sug-
ests that the chlorella viruses and their genes have a
ong evolutionary history. Additionally, six of the seven
BCV-1-encoded putative glycosyltransferases resemble
acterial enzymes (Table 2). Therefore, could Vp54 gly-
osylation occur by an ancestral pathway that existed
rior to ER and Golgi formation?
MATERIALS AND METHODS
hlorella growth and virus infections
The hosts for the chlorella viruses, Chlorella strain
C64A and Chlorella strain Pbi, were grown on MBBM
edium (Van Etten et al., 1983a) and FES medium
Reisser et al., 1988), respectively. Procedures for pro-
ducing, purifying, and plaquing virus PBCV-1 and the
other chlorella viruses and the isolation of host and virus
DNAs have been described previously (Van Etten et al.,
1981, 1983a,b).
Virus recombination conditions were essentially as
described by Tessman (1985). Briefly, 1-ml cultures of
Chlorella NC64A (1.8–2.0 3 107 cells) were inoculated
ith each virus individually or in pairs at an m.o.i. of 5
i.e., 1 3 108 plaque-forming units of each virus). Cells
were incubated until lysis was complete (typically over-
night). Lysates were analyzed by the plaque inhibition
assay by combining 50 ml lysate with 50 ml of the appro-
priate antisera (1:250 dilution of each antiserum) in a
1.5-ml microfuge tube, incubating at room temperature 60
min, and removing the agglutinated virus by centrifuga-
tion at 4000 g for 4 min (Chase et al., 1989). Resultant
supernatants were directly mixed with host cells and
plated or diluted with 50 mM Tris (pH 7.8) (from 1024- to
1026 fold), mixed with host cells, and then plated.
loning and sequence analysis
The a64r gene, including 90 bp upstream of the start
odon and 83 bp downstream of the stop codon (bases
4869 to 36958 in the PBCV-1 sequence, total of 2090
p), was amplified from the genomic DNAs of PBCV-1
nd each of the antigenic mutants with a PCR protocol
sing 0.5 units Vent DNA polymerase (New England
ioLabs, Beverly, MA), 0.5 mM each dNTP, 4 mM MgCl2,
.5 mM each primer, and 20 ng viral DNA in a total of 50
ml. The forward (GAGTGGATCCTAAAATTACGAGTG
GAGGCC) and reverse (GTCAGGTACCTTTGTCATTTGT-
CATCTCCC) primers contained BamHI and KpnI sites,
respectively, for cloning. Amplified fragments were di-
gested with BamHI and KpnI and ligated into appropri-
ately digested pBluescript II KS(2), and resulting plas-
mids were transformed into E. coli stain DH5a (mcr). Thenucleotide sequences of at least two independent
clones from each virus isolate were determined at the
DNA Sequencing Core Facility, Center for Biotechnology,
University of Nebraska at Lincoln. Sequence analysis
employed the GCG Sequence Analysis Software Pack-
age Version 10.1 (Genetics Computer, Inc.). The se-
quences of the a64r genes from viruses EPA-1, EPA-2,
EPA-3, P31, E11, and P100 are in the DDBJ/EMBL/Gen-
Bank databases under Accession Nos. AF327073,
AF327074, AF327075, AF327076, AF327077, and
AF327078, respectively.
To determine the origin of a64r from the recombinant
iruses, the gene was PCR amplified from each virus as
escribed above. The products (5 ml of the reaction)
were digested with HinfI; fragments were separated on
4% agarose gels, stained with ethidium bromide, and
then visualized by UV illumination. To determine the
origin of a122r, 1.3 mg of each virus genomic DNA was
digested with BamHI; fragments were separated on
0.75% agarose gels, stained with ethidium bromide, and
then visualized by UV illumination.
Mass spectrometry
Protein Vp54 was partially purified as described by
Graves and Meints (1992) by heating PBCV-1 virus at
60°C for 30 min to dissociate the virus. This treatment
releases the Vp54 protein as a soluble trimer. Insoluble
material was removed by centrifugation at 14,000 g for 5
in and total proteins were precipitated from the super-
atant using 5 volumes of acetone. The precipitated
roteins were solubilized in 62.5 mM Tris (pH 6.8), 3%
DS, 20% glycerol, 10 mM dithiothreitol (DTT), heated at
00°C (to dissociate the Vp54 trimer into its monomeric
orm), and separated on 10% acrylamide gels using the
uffer system of Laemmli (1970). Proteins were visual-
zed with Coomassie Brilliant Blue R250 and the Vp54
onomer band was excised and the protein eluted from
he acrylamide slices with 50 mM Tris (pH 7.8), 5 mM
TT, 0.1% SDS at 37°C for 15 h. Final purification of Vp54
as achieved by reversed-phase HPLC using a C-4
acked column (Vydac) and a gradient increasing from 5
o 90% acetonitrile/water at a rate of change of 1%/min.
he flow rate was 1 ml/min. The protein was detected by
bsorbance at 280 nm. Fractions were collected from
he HPLC eluent and mass analyzed using a Micro-
ass Platform single-quadrupole mass spectrometer
quipped with an electrospray ionization source. Sam-
les were infused into the source at a flow rate of 5
ml/min. The instrument was operated in the positive ion
mode, scanning the mass range from 300 to 2000 dal-
tons in 10 s. Instrument mass calibration was performed
using a standard solution of myoglobin (5 pmol/ml) in 1:1
water:acetonitrile with 0.1% formic acid. The mass accu-
racy of the Platform instrument is 60.05%.
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Chlorella cells (1 3 109) were collected at various
imes after PBCV-1 infection (m.o.i. of 5), frozen in liquid
itrogen, and stored at 280°C. RNA was extracted using
he Trizol reagent (Gibco BRL, Gaithersburg, MD), sepa-
ated under denaturing conditions on 1.5% agarose/form-
ldehyde gels, stained with ethidium bromide, and trans-
erred to nylon membranes. The RNA was hybridized at
5°C in 50 mM NaPO4, 1% bovine serum albumin, 2%
SDS to an a64r-specific, ssDNA sense probe labeled
with 32P using a random-primed DNA labeling kit (Gibco
BRL) in which the random primers were replaced with
the a64r reverse primer used in the PCR. After hybridiza-
tion, radioactivity bound to the membranes was detected
and quantified using a Storm 840 PhosphorImager and
ImageQuant software (Molecular Dynamics, Inc., Sunny-
vale, CA). To monitor possible loading differences be-
tween samples, the relative amount of the 3.6-kb rRNA in
each lane was determined by converting the photo-
graphs of the stained membranes to digital images using
a Hewlett–Packard ScanJet 4C scanner and analyzing
the images with ImageQuant software.
Chlorella virus DNAs for dot blots were denatured and
applied to nylon membranes (Micron Separation, Inc.,
Westborough, MA), fixed by UV cross-linking, and hybrid-
ized with the same a64r gene probe used for the North-
ern analyses. Radioactivity bound to the filters was de-
tected as described above.
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